GH Guardant Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GH

Price (delayed)

$33.02

Market cap

$4.04B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.96

Enterprise value

$4.23B

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health ...

Highlights
The EPS is up by 39% year-on-year and by 7% since the previous quarter
Guardant Health's net income has increased by 31% YoY and by 3.9% QoQ
Guardant Health's quick ratio has increased by 10% YoY but it has decreased by 10% from the previous quarter
GH's equity has shrunk by 57% QoQ
Guardant Health's gross margin has decreased by 4.4% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.guardanthealth.com
Peers: NEOG NTRA MYGN

Key stats

What are the main financial stats of GH
Market
Shares outstanding
122.37M
Market cap
$4.04B
Enterprise value
$4.23B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
58.86
Price to sales (P/S)
6.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.01
Earnings
Revenue
$603.73M
EBIT
-$457.47M
EBITDA
-$414.22M
Free cash flow
-$300.71M
Per share
EPS
-$3.96
Free cash flow per share
-$2.47
Book value per share
$0.56
Revenue per share
$4.96
TBVPS
$13.91
Balance sheet
Total assets
$1.7B
Total liabilities
$1.64B
Debt
$1.32B
Equity
$68.29M
Working capital
$1.09B
Liquidity
Debt to equity
19.32
Current ratio
5.95
Quick ratio
5.52
Net debt/EBITDA
-0.46
Margins
EBITDA margin
-68.6%
Gross margin
60.4%
Net margin
-76.3%
Operating margin
-87.8%
Efficiency
Return on assets
-25.9%
Return on equity
-246.5%
Return on invested capital
-21.4%
Return on capital employed
-30.8%
Return on sales
-75.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GH stock price

How has the Guardant Health stock price performed over time
Intraday
3.41%
1 week
7.38%
1 month
12.35%
1 year
-14.23%
YTD
22.07%
QTD
14.34%

Financial performance

How have Guardant Health's revenue and profit performed over time
Revenue
$603.73M
Gross profit
$364.45M
Operating income
-$530.35M
Net income
-$460.9M
Gross margin
60.4%
Net margin
-76.3%
The net margin is up by 45% year-on-year and by 10% since the previous quarter
Guardant Health's net income has increased by 31% YoY and by 3.9% QoQ
Guardant Health's revenue has increased by 25% YoY and by 7% from the previous quarter
The company's operating margin rose by 24% YoY and by 12% QoQ

Growth

What is Guardant Health's growth rate over time

Valuation

What is Guardant Health stock price valuation
P/E
N/A
P/B
58.86
P/S
6.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.01
The EPS is up by 39% year-on-year and by 7% since the previous quarter
The P/B is 168% more than the last 4 quarters average of 21.2
GH's equity has shrunk by 57% QoQ
The P/S is 72% below the 5-year quarterly average of 23.0 but 9% above the last 4 quarters average of 5.9
Guardant Health's revenue has increased by 25% YoY and by 7% from the previous quarter

Efficiency

How efficient is Guardant Health business performance
The ROE has soared by 54% YoY and by 18% from the previous quarter
The return on sales is up by 45% year-on-year and by 10% since the previous quarter
GH's ROA is up by 35% year-on-year and by 6% since the previous quarter
Guardant Health's ROIC has increased by 15% YoY but it has decreased by 4.4% from the previous quarter

Dividends

What is GH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GH.

Financial health

How did Guardant Health financials performed over time
Guardant Health's total assets is 4.2% more than its total liabilities
Guardant Health's total assets has increased by 13% YoY but it has decreased by 4.6% from the previous quarter
GH's current ratio is up by 10% year-on-year but it is down by 9% since the previous quarter
GH's debt to equity has surged by 164% year-on-year and by 131% since the previous quarter
GH's equity has shrunk by 57% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.